Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 26.05.2021.

Biotechnology
Medicine
Venture capital
NASA
Organ transplant
Quality assurance

Startups

@matthewherper shared
On May 24, 2021
RT @hiltzikm: Column: California's stem cell program found a disease cure, but it's being blocked by a biotech firm https://t.co/cCJMaExeA3
Open
Column: California’s stem cell program found a disease cure, but it’s being blocked by a biotech firm

Column: California’s stem cell program found a disease cure, but it’s being blocked by a biotech firm

A biotech firm has halted work on a state-funded disease cure, purely for its bottom line.

@big4bio shared
On May 24, 2021
#LifeSciences Startups: Learn how to initiate #StrategicPartnerships that can catapult your innovation to market! Join @UMassM2D2 June 17. KEYNOTE SPEAKER: Bruce J. Tromberg, PhD —Director of @NIBIBgov at @NIH  https://t.co/Eq6TfBQyc6 @UMassMedical @NIH https://t.co/iW9cdnjNno
Open
Organizer of 2021 CAPCaT Big Company/Little Company Showcase

Organizer of 2021 CAPCaT Big Company/Little Company Showcase

See 8 breakthrough point-of-care innovations and learn about strategic partnership and grant opportunities that can accelerate YOUR startup.

@Forbes shared
On May 25, 2021
Miami Just Rolled Out Its Newest Red Carpet To The Tech World. Are San Francisco And Austin Paying Attention? https://t.co/m19sCm1P8E
Open
Miami Just Rolled Out Its Newest Red Carpet To The Tech World. Are San Francisco And Austin Paying Attention?

Miami Just Rolled Out Its Newest Red Carpet To The Tech World. Are San Francisco And Austin Paying Attention?

Miami and its newly minted 'Time 100' Mayor Francis Suarez are showing no signs of slowing down their charm offensive to make 'Silicon Beach' the next technology and innovation capital of ...

@Forbes shared
On May 25, 2021
This cloud startup raised $50 million to help biopharma companies automate quality control: https://t.co/5fJ1RHu92u https://t.co/99uaGVQrN3
Open
This Cloud Startup Raised $50 Million To Help Biopharma Companies Automate Quality Control

This Cloud Startup Raised $50 Million To Help Biopharma Companies Automate Quality Control

San Francisco-based Qualio is modernizing a niche area thrust into the spotlight by production issues with Covid-19 vaccines.

@FierceBiotech shared
On May 25, 2021
The candidates will be developed to what Alloy and Pyxis call a “value-inflection point,” at which point the companies expect they will be eligible for independent funding and partnering with other pharmas https://t.co/crUhLikaEe
Open
New JV from upstart biotechs Pyxis, Alloy aims for rapid drug development in cancer, autoimmune diseases

New JV from upstart biotechs Pyxis, Alloy aims for rapid drug development in cancer, autoimmune diseases

Kyma Therapeutics from Alloy Therapeutics and Pyxis Oncology will work on immune-modulating targets selected in cancer and autoimmune diseases. The candidates will be developed to what ...

@FierceBiotech shared
On May 20, 2021
Chief executive and president Andre Turenne is to leave the company from next month “to pursue new opportunities.” https://t.co/UbSym7Ui7Z
Open
Bon voyage: Voyager Therapeutics’ CEO, R&D chief exit as beleaguered biotech looks to the future

Bon voyage: Voyager Therapeutics’ CEO, R&D chief exit as beleaguered biotech looks to the future

Battered and bruised by a tough journey, the Voyager 1 space probe is exiting our Solar System into worlds unknown; now, those running its earthly biotech namesake are taking a similar same ...

@FierceBiotech shared
On May 26, 2021
The track record of success inside and outside of Spain has helped Ysios raise its biggest fund yet https://t.co/a9lLEwxkbw
Open
Spanish VC Ysios bags €216M to build EU-skewed biotech portfolio

Spanish VC Ysios bags €216M to build EU-skewed biotech portfolio

Ysios Capital has closed its third fund at €216 million ($265 million). The fund, the largest raised by Ysios to date, equips the Spanish VC shop to invest in up to 15 companies in Europe ...

@MassBio shared
On May 20, 2021
MassBio is proud to announce the appointment of Robert K. Coughlin, Managing Director, Life Sciences, JLL & Michal Preminger, PhD, MBA, Head, Johnson & Johnson Innovation LLC, East North America to the organization’s Board of Directors. Learn more: https://t.co/mlWCviY6ix
Open
MassBio® Welcomes Two Members to its Board of Directors

MassBio® Welcomes Two Members to its Board of Directors

The Massachusetts Biotechnology Council (MassBio®) today announced the appointment of two life sciences executives to the organization’s Board of Directors.